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Abstract 
Oral cavity suffers a short-term and long-term complication from cancer therapy. An appropriate evaluation and 
elimination of potential source of oral infection before cancer therapy is vital and must. The best management 
strategy encompasses a prophylactic local and systemic combination therapy that has implications for post-
treatment oral comfort and function, thus promoting consistent high standards of oral care through a co-
ordinated team approach is warranted. This paper provides a multidisciplinary oral management prior to cancer 
therapy.   
Keywords: Cancer therapy; Oral care; Oral prophylaxis. 
1. Introduction  
The management of dental diseases before cancer therapy poses many challenges to dental practitioners. Oral 
cavity has been common ground of short-term and long-term complications from cancer therapy that may 
require modification of dental management strategy. Dental treatment may also require modifications in 
situations where it must be delivered expeditiously and little time to institute an ideal treatment plan. As stated 
there is insufficient time period between diagnosis of cancer and commencement of cancer treatment.  
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This shortage of time along with failure to consider the oral implication at high priority often compromises 
complex emergency invasive dental treatments. Hence, it is warranted that patients and carers are educated and 
motivated about oral care procedures [1]. Hence, a pathway of management should be considered and executed 
under as immediate therapy phase and followed by reassessment phase. Immediate therapy phase is aimed at 
identifying etiological factors, relieving sensitivity and pain and protecting remaining oral hard and soft tissue. 
Although, full compliance may be difficult. At very least a “Damage Limitation” pathway can be initiated. This 
involves the identification, control and referral for advice relating to problem under consideration. Consideration 
should be given as diet analysis and counselling to control or reduce the effect of aetiological factors, 
prescription of neutral, sodium fluoride mouthrinses or gel for daily use, direct application of glass ionomer 
and/or composite to sensitive areas, thorough oral prophylaxis, consultation with oncologic team for further 
referral. The reassessment phase should include whether the original aetiolgical factors are eliminated/ stabilize 
to cause no further damage. Reassessment period involves review & monitoring of oral conditions and be should 
at least be equivalent to the period of monitoring of cancer by the Oncology team.  (Figure 1) 
 
 
Figure 1. Oral Assessment and Management prior to cancer therapy 
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2. Oral management of a patient in preparation for cancer therapy  
2.1 Pre-treatment oral evaluation  
Pre-treatment oral evaluation depends on the cancer diagnosis and planned cancer therapy. The patients most 
frequently seen before chemotherapy or radiation are those with highest risk for developing short-term and long-
term complications. This includes the patient undergoing chemotherapy followed by hematopoietic stem cell 
transplantation (HSCT). These patients are at high risks for infectious complications during the period of 
pancytopenia. Another group includes patients who require head and neck radiation therapy. Radiation at 
therapeutic doses induces long-term irreversible damage to hard & soft tissue of oral cavity and associated 
glands and, in particular the mandible [2]. 
Ideally, a comprehensive oral evaluation should take place 1 month before cancer treatment to allow adequate 
recovery time from any required invasive dental procedures. A comprehensive oral assessment should be done 
as this will help to identify existing oral disease and potential risk of oral disease, remove infectious dental/oral 
foci before the start of cancer therapy, prepare the patient for expected side effects of cancer therapy, establish 
an adequate standard of oral hygiene to meet the increased challenge, develop a plan for maintaining oral 
hygiene, providing preventive care and follow-up, establish the necessary multidisciplinary collaboration to 
reduce/alleviate oral symptoms and sequelae before, during and after cancer therapy. 
As noticed there is no universally accepted pre-cancer therapy dental protocol because of the lack of clinical 
trials evaluating the efficacy of a relevant cancer therapy related protocol [3, 4]. 
• Teeth in direct association with the tumour or the radiation beam and teeth with doubtful prognosis 
should be extracted before radiotherapy. Teeth should be removed with a minimum of trauma and if 
possible primary closure achieved. Ideally allow three weeks for maximal healing time before 
radiotherapy. Ten days should be considered a minimum period [5, 6].  
• Any faulty restorations or sharp edges of teeth should be reduced to decrease the risk of trauma to the 
associated oral mucosa [7]. 
• The use of an aqueous alcohol free chlorhexidine mouthwash (10ml of 0.2% aqueous alcohol free 
chlorhexidine gluconate mouthwash or 18ml of 0.12% aqueous chlorhexidine gluconate solution twice 
daily for at least one week prior to commencing treatment) or dental gel in combination with thorough 
oral hygiene practices showed evidence that it reduces the incidence of oral complications. In children 
chlorhexidine is rarely used unless toothbrushing cannot be performed [8].  
• When maxillary surgery is to be combined with radiotherapy, diagnostic casts should be prepared for 
obturator planning in liaison with the surgical team.  
• Where time permits it is preferable to restore teeth with a permanent restorative material. During 
limited time period glass ionomer cements make an effective restoration.  
• For children the recommendations for oral care at the time of diagnosis has been made which involve 
the removal of all primary teeth within three months of exfoliation and those with any risk of pulpal 
involvement [4]. The children are advised to brush at least twice a day, with fluoride toothpaste 
appropriate and in accord to the age and toothbrush should be changed on either a three month basis or 
when bristles splay, if earlier and especially, following an oral infective episode. If the child has a sore 
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mouth a soft brush with a small head should be used [8, 9]. Children need to be helped or supervised by 
an adult until at least 7 years of age, parents/carers should be instructed on how to brush their child‘s 
teeth. For babies without teeth, parents/carers should be instructed on cleaning the mouth with oral 
sponges/soft brush or gauze as temporary measure. These items should be moistened with water or an 
antimicrobial agent such as diluted alcohol-free chlorhexidine. The need to restrict sugary food and 
drink to meal times only should be emphasised. Children undergoing orthodontic therapy should have 
their orthodontic appliance removed and treatment discontinued until one year after completion of 
cancer treatment [10]. 
• For adults, a restorative and reconstructive dentist should work with the surgeon as a multidisciplinary 
team, especially if surgery to the jawbone is planned. It has been reported that 78% of patients 
experience severe difficulties in mastication following major head and neck surgery [11]. Oral surgical 
procedures should be performed at least seven to ten days before the patient receives myelosuppressive 
chemotherapy. Oncologic consultation is indicated prior invasive procedures [8]. Guidelines for 
extractions, endodontic treatment, and other dental interventions can be used as suitable [11, 12].  
 
However, if the patient were gravely ill and dental treatment would delay chemotherapy, indicated dental 
treatment by necessity will need to be postponed until the patient is between courses of chemotherapy and when 
haematological value permit. Such scenario occurs particularly, in that case of a haematologic malignancy. In all 
such cases, consultation with the managing physician is warranted to determine the patient’s ability to undergo 
the anticipated dental therapy.   
3. Conclusion   
Patient education and motivation should be an integral part of the pre-treatment evaluation and should include a 
discussion of potential oral complications. It is must that the dental team imprints on the patient regarding 
optimal oral hygiene practice during treatment, avoiding tobacco and alcohol and adequate nutrition can 
minimise post-treatment oral complications and reduce recurrence/further cancers. It is warranted that dental 
team should ensure that the patient fully recognition of signs of complications, understands detailed instructions 
on specific oral care practices, and other instructions suitable for the individual. Such pre-treatment oral care 
and function is an important contributor to post-treatment social adaptation and life quality. Hence, appropriate 
preventive regimens and timely oral care can minimize complications and improve quality of life.  
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